Overexpression of insulin-like growth factor binding protein-5 decreases osteoblastic function in vitro

D Durant1, R M R Pereira, E Canalis

  • 1Department of Research, Saint Francis Hospital and Medical Center, Hartford, CT 06105-1299, USA.

Bone
|December 14, 2004
PubMed

Insights

Insulin-like growth factor-binding protein-5 (IGFBP-5) overexpression in bone cells reduces osteoblastic function and hinders bone formation. This study clarifies IGFBP-5

Area of Science:

  • Bone Biology
  • Cellular and Molecular Medicine
  • Endocrinology

Background:

  • Skeletal cells produce insulin-like growth factors (IGFs) and their binding proteins (IGFBPs).
  • The role of IGFBP-5 in bone cell function is debated, with some studies showing osteopenia in transgenic mice overexpressing IGFBP-5.
  • Mechanisms underlying IGFBP-5's effects on bone cells remain unclear.

Purpose of the Study:

  • To investigate the in vitro effects of IGFBP-5 overexpression on osteoblastic function using MC3T3 cells.
  • To elucidate the cellular and molecular mechanisms by which IGFBP-5 influences bone cell differentiation and activity.

Main Methods:

  • MC3T3 cells were transduced with retroviral vectors, one expressing IGFBP-5 under a constitutive promoter.
  • Gene expression of osteoblastic markers (alkaline phosphatase, osteocalcin, type I collagen, osteopontin) was analyzed.
  • Alkaline phosphatase activity and mineralized nodule formation were assessed.

Main Results:

  • IGFBP-5 overexpression delayed the expression of alkaline phosphatase and osteocalcin mRNA.
  • Type I collagen and osteopontin mRNA levels and alkaline phosphatase activity were reduced.
  • The formation of mineralized nodules was inhibited, although DNA synthesis was modestly stimulated.

Conclusions:

  • Overexpression of IGFBP-5 in MC3T3 cells impairs osteoblastic differentiation and function.
  • IGFBP-5 may decrease osteoblastic function by sequestering IGFs within the bone microenvironment.
  • These findings provide insights into the role of IGFBP-5 in bone metabolism and potential mechanisms of osteopenia.